TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Changes in cardiovascular disease (CVD) risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sufentanil dosage reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loading tooth strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in clinical scores (PCDAI and PUCAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in inflammatory markers (CRP, calprotectin, TNF‐α, IL17, IL12, IL13)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of ICU or NCU stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: successful puncture time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Blockage rate of all 4 nerves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IBD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 6-hr areas under the glucose curves
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Response rate of survey completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Children's raw and standardized scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety levels before surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rates of postpartum endometritis
Endpoint domain: Adverse events/effects
Primary endpoint: Rates of respiratory distress syndrome (RDS)
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of low milk retinol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean milk retinol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with optimal intravascular attenuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Contrast-to-Noise Ratio (CNR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of scans with good-excellent image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time in range 70-180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: one-year EI
Endpoint domain: Mortality/survival
Primary endpoint: one-year HEMI
Endpoint domain: Mortality/survival
Primary endpoint: CR
Endpoint domain: Mortality/survival
Primary endpoint: Maximum concentrations of CBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative bioavailability of CBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posterior wall puncture rates
Endpoint domain: Adverse events/effects
Primary endpoint: Average number of complete bowel movements per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: BSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement rate of constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Non-cardiovascular deaths
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in global pragmatic skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Improvement in metaphor comprehension
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Beneficial effects on functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: speed of submucosal dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KOOS5 score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Recall and comprehension of core elements
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: YBT improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved executive functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased right frontal EEG power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: case review completion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean visual analogue scale (VAS) pain assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ODRS (Overall Disability Rating Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ileus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of all types of arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Albumin loss per session
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Removal of molecules around 20,000
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: everyday use of the more-affected arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum pulling strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant comfort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Achievement of higher threshold efficacy end points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (QoL) benefits
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of ankle and knee injuries
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of halo or TA occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unilateral pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: autonomic cardiac function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sufficient relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gastric variceal rebleeding
Endpoint domain: Mortality/survival
Primary endpoint: all-cause rebleeding
Endpoint domain: Mortality/survival
Primary endpoint: Weight loss ≥ 5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Nutritional status scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of symptoms associated with the disease
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vitamin D serum concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year health status (KCCQ scores)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Trismus and facial swelling values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in psycho-emotional state
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increase in vitamin D levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: psychological flourishing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: HTG prevalence rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EAS muscle contractility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of fecal incontinence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean pain score immediately after injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular staining score indicating corneal epitheliopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User experience with UpToDate
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of answers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required for answering clinical questions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cyclic displacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of perceived exertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of minor and major deviations in contouring and dosimetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication adherence knowledge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medication adherence behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent Low Back Pain (LBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day ED revisits
Endpoint domain: Mortality/survival
Primary endpoint: in-person follow-up with outpatient clinicians
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: recalling at least one red flag from ED discharge instructions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: plasma concentration of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: fat emptying from the HGS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: decrease in pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Post-processing state anxiety levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial expressions rating scale score averages
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relieving pain, symptoms, and disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erythrocyte Zn concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of HAP
Endpoint domain: Adverse events/effects
Primary endpoint: Bifidobacteriaceae levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacteroidaceae and Lachnospiraceae levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NIHSS score improvement at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracranial hemorrhage occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Life-years (LYs)
Endpoint domain: Mortality/survival
Primary endpoint: Prevalence of self-medication
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incremental AUC (iAUC) for %FMD response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incremental AUC (iAUC) for apoB response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incremental AUC (iAUC) for plasma total SFAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Efficacy of exercise program
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cognitive task load
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: survival of ICU patients
Endpoint domain: Mortality/survival
Primary endpoint: MDS-UPDRS III score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence in tool use
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total pregnancy loss
Endpoint domain: Mortality/survival
Primary endpoint: Live birth rate (LBR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of NCD
Endpoint domain: Mortality/survival
Primary endpoint: low-density lipoprotein cholesterol (LDL-c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: non high-density lipoprotein cholesterol (non-HDL-c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 12-month failure rates
Endpoint domain: Mortality/survival
Primary endpoint: Increases in MART‐1a‐specific T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in VFSS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean FA value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental scale of BSID II
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEDI (social function)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: LAB-TAB (observation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flow-mediated dilatation of the brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in serum FABP4 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain score during intravenous cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anxiety levels pre- and postprocedural
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction of CFUs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: between-session decline in spending on cigarette trials
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants achieving target BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in number of antihypertensive pills
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Difference in percentage conversion of 11β‐HSD1 activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of catheter-related infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Efficacy of ACBMNC infusion in preventing BPD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upgrade to invasive carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: additional park visits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: additional minutes of park-based PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shifts in microbial composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Endorsement of epilepsy as a contagion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Support or belief in the basic rights of people with epilepsy (PWE)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: 24-h urine protein reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rate of weight loss on postoperative day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of muscle loss in the erector spinae muscle on postoperative day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: lifestyle change intentions
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: numeric risk perception
Endpoint domain: Life impact
Endpoint subdomain: perceived health status
Primary endpoint: risk of overweight/obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: risk of underweight/wasting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time from randomization to an inadequate analgesic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abnormal bladder outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: erosion improvement rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: DKA resolution at 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DKA resolution at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ownership of at least one LLIN
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Adequate access of bed nets to household members
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Utilization of LLIN by children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Re-engagement rates within 90 days
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: knee joint angular velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertical ground reaction force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee varus moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: height-for-age z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in assessed parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentage adherence to the CONSORT statement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 2-year seizure occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hopkins Verbal Learning Test‐Revised (HVLT‐R) retention raw score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient-rated CGI-I scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Errors managing BDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Interpreting cholangiograms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Conversion to open operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: pain on palpation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: granulation tissue appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal shape improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications (acute infection, cartilage absorption, recurrence of drooping nose)
Endpoint domain: Adverse events/effects
Primary endpoint: Patient satisfaction with effectiveness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postoperative mortality proportion
Endpoint domain: Mortality/survival
Primary endpoint: Likelihood of reporting counselor discussions about sex
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Persistent CIN-1 diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: global symptom severity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Abdominal wall complications requiring reoperations
Endpoint domain: Adverse events/effects
Primary endpoint: soluble CD40 ligand concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: chemokine ligand 5 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cell-free hemoglobin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right hippocampal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: symptom relapse rates
Endpoint domain: Mortality/survival
Primary endpoint: mean root closure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite outcome for the TCC group
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent documenting away from the patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Time elapsed between the end of the visit and the start of dictation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gut Actinobacteria residency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum LDL.C/HDL.C ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic accuracy of PCT compared to CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibacterial exposure
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: incremental cost effectiveness ratio
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Development of SARS-CoV-2 antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Recall for affective information
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: femoral nerve MCV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes